NCT02183142View on ClinicalTrials.gov

Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

April 30, 2001

Conditions
Healthy
Interventions
DRUG

Mobic, China, 7.5 mg

DRUG

Mobic, Germany, 7.5 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY